Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 235089 |
| Drug Identification Number | 02402084 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
| Strength(s) | 0.5G 4G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-12 |
| Estimated end date | Unknown |
| Actual end date | 2025-02-18 |
| Shortage status | Resolved |
| Updated date | 2025-02-19 |
| Company comments | Please be informed that PIPERACILLIN AND TAZOBACTAM INJECTION will be transferred to the Eugia label, DIN:02528711 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-02-19 | French | Compare |
| v9 | 2025-02-19 | English | Compare |
| v8 | 2024-09-19 | French | Compare |
| v7 | 2024-09-19 | English | Compare |
| v6 | 2024-08-23 | French | Compare |
| v5 | 2024-08-23 | English | Compare |
| v4 | 2024-08-13 | English | Compare |
| v3 | 2024-08-12 | French | Compare |
| v2 | 2024-08-12 | English | Compare |
| v1 | 2024-08-12 | English | Compare |
Showing 1 to 10 of 10